MedPath
NMPA Approval

Dinutuximab beta Injection

国药准字SJ20210023

August 12, 2021

Drug Information

达妥昔单抗β注射液

凯泽百

注射剂

20mg(4.5ml)/瓶

生物制品

August 12, 2021

August 11, 2026

Company Information

Applicant Company

Beechavenue 54, 1119PW Schiphol-Rijk, Netherlands

Manufacturing Company

PATHEON ITALIA SPA

2° Trav. SX Via Morolense, 5 03013 Ferentino, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

达妥昔单抗β注射液 - NMPA 批准文号 | MedPath